Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Diabetes Care
|
August 29, 2025
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study
Samuel Dagogo-Jack, Erin J Kazemi, Lindsay Doherty, et al.
Diabetes Care
|
August 26, 2025
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
Emily Kobayashi, Nathaniel J Linden-Santangeli, Nicholas Chan, et al.
Schizophrenia Research
|
July 18, 2006
A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial
Christine L McKibbin, Thomas L Patterson, Gregory Norman, et al.
Diabetes
|
January 5, 2002
Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects
Theodore P Ciaraldi, Alice P S Kong, Neelima V Chu, et al.
Diabetes Care
|
September 27, 2012
Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes
Sunder Mudaliar, Debra A Armstrong, Annie A Mavian, et al.
Scientific Reports
|
April 6, 2019
Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly
Vikram Singh Shekhawat, Shobhit Bhansali, Pinaki Dutta, et al.
Diabetes, Obesity & Metabolism
|
November 18, 2018
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Kenneth Cusi, Fernando Bril, Diana Barb, et al.
Gastroenterology
|
June 4, 2013
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease
Sunder Mudaliar, Robert R Henry, Arun J Sanyal, et al.
Stem Cells and Development
|
December 24, 2016
Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study
Shobhit Bhansali, Pinaki Dutta, Vinod Kumar, et al.
Diabetology & Metabolic Syndrome
|
July 11, 2017
Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity
Shobhit Bhansali, Pinaki Dutta, Mukesh Kumar Yadav, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Diabetes Care
|
August 29, 2025
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study
Samuel Dagogo-Jack, Erin J Kazemi, Lindsay Doherty, et al.
Diabetes Care
|
August 26, 2025
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
Emily Kobayashi, Nathaniel J Linden-Santangeli, Nicholas Chan, et al.
Schizophrenia Research
|
July 18, 2006
A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial
Christine L McKibbin, Thomas L Patterson, Gregory Norman, et al.
Diabetes
|
January 5, 2002
Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects
Theodore P Ciaraldi, Alice P S Kong, Neelima V Chu, et al.
Diabetes Care
|
September 27, 2012
Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes
Sunder Mudaliar, Debra A Armstrong, Annie A Mavian, et al.
Scientific Reports
|
April 6, 2019
Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly
Vikram Singh Shekhawat, Shobhit Bhansali, Pinaki Dutta, et al.
Diabetes, Obesity & Metabolism
|
November 18, 2018
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Kenneth Cusi, Fernando Bril, Diana Barb, et al.
Gastroenterology
|
June 4, 2013
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease
Sunder Mudaliar, Robert R Henry, Arun J Sanyal, et al.
Stem Cells and Development
|
December 24, 2016
Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study
Shobhit Bhansali, Pinaki Dutta, Vinod Kumar, et al.
Diabetology & Metabolic Syndrome
|
July 11, 2017
Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity
Shobhit Bhansali, Pinaki Dutta, Mukesh Kumar Yadav, et al.
Page
of 9